Study of Safety, Tolerability & Efficacy in Cystic Fibrosis Patients With Abnormal Glucose Tolerance
Clinical trial NCT02955888 · TERMINATED
Trial details
- NCT number
- NCT02955888
- Sponsor
- Liminal BioSciences Ltd.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-03
- Primary completion
- 2018-02-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.